3 天之前 · Should You Buy or Sell Acasti Pharma Stock? Get The Latest ACST Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

Acasti Pharma, Inc. Class A Common Stock (ACST) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

The latest Acasti Pharma stock prices, stock quotes, news, and ACST history to help you invest and trade smarter.

Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

/PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST and TSX-V: ACST) a late-stage, specialty pharma company advancing three clinical... The Quote Overview page gives you a snapshot view for a specific symbol. Real-time prices are provided by Cboe BZX Exchange on individual U.S. equities quote pages.

2024年7月15日 · Get Acasti Pharma Inc (ACST.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Grace Therapeutics, Inc. will Change its Ticker to GRCE from ACST 24-10-28: CI Acasti Pharma Inc. will Change its Ticker to GRCE from ACST 24-10-28: CI Acasti Pharma Changes Name to Grace Therapeutics 24-10-25

Real-time Price Updates for Acasti Pharma (ACST-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more

2024年8月9日 · Check out our ACST stock analysis, current ACST quote, charts, and historical prices for Acasti Pharma, Inc. - Common Stock stock

Acasti Pharma, Inc. released its earnings results on Aug 09, 2024. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.265 by $0.025. Is Acasti Pharma, Inc. overvalued? According to Wall Street analysts Acasti Pharma, Inc.’s price is currently Undervalued.